Costs are limiting states’ coverage of obesity drugs and could affect other Medicaid priorities States expect national Medicaid enrollment to decline by about 4% and state Medicaid spending to rise by 7% in fiscal year (FY) 2025. These rates follow a larger but anticipated enrollment decline and state spending increase in FY 2024, as pandemic-era…More
During a panel discussion at HLTH, Chelsea Clinton shared three things she wants healthcare leaders to know going into the election when it comes to reproductive health. The post Chelsea Clinton on Reproductive Rights: 3 Things to Know appeared first on MedCity News.
Virtual-first partner company Ovatient was formed through a partnership between MetroHealth and South Carolina-based MUSC Health in October 2022
Avandra Imaging, a federated network for de-identified imaging data, emerged from stealth at HLTH — as well as announced a partnership with Datavant. The post Avandra Imaging Emerges from Stealth to Solve a Last-Mile Problem in Medical Research appeared first on MedCity News.
Amazon One Medical said it will open its first primary care office in affiliation with Cleveland Clinic next year
A just-released report from SullivanCotter sees salaries and incentive pay creeping up
HealthEx is building a consumer preference and consent platform for healthcare
Editas Medicine says its in vivo gene-editing therapy for hemoglobinopathies has best-in-class potential, but the company plans to out-license or partner that program. Editas is shifting focusing to in vivo gene-editing therapies. The post Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D appeared first on MedCity News.
Both providers and payers face challenges and understanding the requirements and needs of each stakeholder has the potential to lower the temperature of the current rhetoric. The post Analyzing the Medicare Advantage Terminations: Concerns, Drivers, and Solutions appeared first on MedCity News.